STOCK TITAN

Heska to Host Virtual 2022 Investor Day on May 17, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

LOVELAND, Colo., April 29, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, plans to host its 2022 Investor Day in a virtual format on Tuesday, May 17, 2022 at 9:00 a.m. MT / 11:00 a.m. ET. Members of Heska's leadership will provide strategic updates and discuss the Company's key growth drivers.

Company presentations will cover:

  • Heska Position in Global Veterinary Health Market
  • Heska Strategic Plan 2023 – 2027:  Win at Scale and Reinvention
  • The Complete Heska Portfolio:  New Products and Services
  • Heska Sales and Profits:  Multi-Year Financial Targets, Key Metrics and Considerations

A question and answer session with management will follow the prepared remarks and formal presentation.

To access the virtual event, register by visiting: https://heska-investor-day-2022.open-exchange.net/. The event will be webcast and the presentations will be posted to Heska's investor relations website. A replay will be available for one year. For additional information or questions, please Contact Investor Relations at investorrelations@heska.com or 970-617-8399.

About Heska 
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostics, informatics, and specialty healthcare solutions through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production for third-parties, primarily for herd animal health. For more information, please visit www.heska.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/heska-to-host-virtual-2022-investor-day-on-may-17-2022-301535280.html

SOURCE Heska Corporation

HSKA

NASDAQ:HSKA

HSKA Rankings

HSKA Latest News

HSKA Stock Data

1.31B
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
US
Loveland

About HSKA

heska corporation (nasdaq: hska) is dedicated to perfecting and supporting the core technology and services that truly impact the quality of pet care and help to ensure positive outcomes for veterinarians and their patients. heska was created by veterinary professionals for veterinary professionals. our pledge to customers is to stand behind sound science, following best medical practices. heska’s line of diagnostic and imaging advancements include state-of-the-art chemistry, hematology, and blood gas & electrolyte systems, as well as single-step heartworm, early renal healthscreens, allergy testing and allergy treatment. heska also leads the way with the latest hd digital radiography, digital ultrasound, and pacs imaging technologies from cuattro. we help veterinary practices discover the right product solutions for their clients and patients; improving patient care, productivity and profitability. heska’s corporate headquarters are in loveland, colorado. we provide our products a